Conservative Treatment of Distal Radius Fracture in Elderly in Randomized Controlled Trial

Summary

There is no consensus about the best conservative treatment for patients with dorsally displaced distal radius fractures. The previous studies that have examined the most valid method for cast immobilization have lacked uniform and patient-rated outcome measures, proper randomization and sufficient study population. The aim of this study is to compare functional position cast to flexion-ulnar -deviation with dorsally displaced distal radius fractures in patients aged 65 years or older. The conservative treatment is performed in clinical practice by various health care professionals with different techniques of reduction which are not limited to any specific technique in this pragmatic, randomized controlled trial.

Conditions

• Colles' Fracture
• Distal Radius Fracture

Interventions

OTHER

Flexion-ulnar cast

The group will be treated with closed reduction and flexion-ulnar deviation position cast. This will take place under local anaesthesia by means of local infiltration commonly used in Finland. There is no preferable method for performing the reduction. Additional radiographs will be taken to verify the success of the reduction one week after the reduction and after two and five weeks of casting if treating health care professional it requires. The cast will be disposed after 5 weeks.

OTHER

Functional cast

The group will be treated with closed reduction and functional position cast. This will take place under local anaesthesia by means of local infiltration commonly used in Finland. There is no preferable method for performing the reduction. Additional radiographs will be taken to verify the success of the reduction one week after the reduction and after two and five weeks of casting if treating health care professional it requires. The cast will be disposed after 5 weeks.

Sponsors & Collaborators

• Central Finland Hospital District

  collaborator OTHER

• Satakunta Central Hospital

  collaborator OTHER

• Tampere University Hospital

  lead OTHER

Principal Investigators

• Ville Mattila, MD, Professor · Tampere Univeristy Hospital

• Antti Launonen, MD, PhD · Tampere University Hospital

• Teemu Hevonkorpi, MBBS · Tampere University Hospital

• Lauri Raittio, MBBS · Tampere University Hospital

• Toni Luokkala, MD · Central Finland Central Hospital

• Aleksi Reito, MD, PhD · Central Finland Central Hospital

• Juha Kukkonen, MD, PhD · Satakunta Central Hospital

• Minna Laitinen, Adjacent prof · Tampere University Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2016-06-30

Primary Completion

2018-04-30

Completion

2018-05-31

Countries

• Finland

Study Locations